Novartis India MD Sanjay Murdeshwar resigns
Novartis India has said its vice chairman and managing director Sanjay Murdeshwar has resigned. The company's board, at its meeting on Thursday, has accepted his resignation, the drug firm said in a regulatory filing.
In India, Novartis has had a significant footprint since 1947. The Company have two legal entities namely, Novartis Healthcare Private Limited (NHPL) and Novartis India Limited (NIL) employing about 10,000 people.
Its rich portfolio of both innovative and established medicines address various therapeutic needs: cardiovascular, eye care, immunology, metabolic, neuroscience, oncology, respiratory and organ transplant, to meet the medical needs of patients in India.
India is amongst a handful of countries in the world that have a broad Novartis footprint covering early research, drug development, technical operations, business services and commercial operations.
Original news source: https://www.ptinews.com/story/business/novartis-india-md-sanjay-murdeshwar-resigns/1241112
Read also: Novartis Gets CDSCO Panel nod to study antimalarial drug KLU156 with Coartem
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.